Literature DB >> 21847758

Application of GP5 protein to develop monoclonal antibody against porcine reproductive and respiratory syndrome virus.

Hong Tian1, Yan Cheng, Jin-yang Wu, Jian-hui He, You-jun Shang, Xiang-tao Liu.   

Abstract

In this study, a panel of monoclonal antibodies (mAbs) against Porcine reproductive and respiratory syndrome virus(PRRSV), named as 8C9 and4B4, were produced by fusing SP2/0 myeloma cells and spleen cells of BALB/c mice immunized with the PRRSV (TCID(50)=5.5), screened by the indirect ELISA and subjected to several limiting dilutions. mAbs were then identified by biological characterization. Among the two fusion cell strains, 8C9 belonged to the IgG1 subclass and 4B4 belonged to the IgG2a subclass. The titers in cell culture supernatant and abdomen liquor reached to 1:10(4)and 1:10(5), respectively. The specificity test indicated that the two cells had specific reactions for the PRRSV and GP5 protein respectively, and no reaction with Classical swine fever virus (CSFV) or Swine vesicular disease virus (SVDV). The molecular weights of the heavy chain and light chain were about 45.0 kDa and 25.0 kDa, respectively. In neutralization activity tests, the results showed that the prepared mAb 4B4 can protect 50% of cells with no CPE in dilution up to 1:512, but mAB 8C9 has no neutralization activities to PRRSV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847758      PMCID: PMC8222479          DOI: 10.1007/s12250-011-3198-5

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  10 in total

Review 1.  Financial evaluation and decision making in the swine breeding herd.

Authors:  D D Polson; W E Marsh; G D Dial
Journal:  Vet Clin North Am Food Anim Pract       Date:  1992-11       Impact factor: 3.357

2.  Genetic variation of Chinese PRRSV strains based on ORF5 sequence.

Authors:  Jian Chen; Tao Liu; Cheng-Gang Zhu; Yong-Feng Jin; Yao-Zhou Zhang
Journal:  Biochem Genet       Date:  2006-09-19       Impact factor: 1.890

3.  Divergence time of porcine reproductive and respiratory syndrome virus subtypes.

Authors:  Roald Forsberg
Journal:  Mol Biol Evol       Date:  2005-07-06       Impact factor: 16.240

4.  A simple, single-step technique for selecting and cloning hybridomas for the production of monoclonal antibodies.

Authors:  J M Davis; J E Pennington; A M Kubler; J F Conscience
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

5.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease.

Authors:  S M Golding; R S Hedger; P Talbot
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

6.  Indirect ELISA with recombinant GP5 for detecting antibodies to porcine reproductive and respiratory syndrome virus.

Authors:  Yan Chen; Hong Tian; Jian-hui He; Jin-yin Wu; You-jun Shang; Xiang-tao Liu
Journal:  Virol Sin       Date:  2011-02-18       Impact factor: 4.327

7.  Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs.

Authors:  C-C Chang; K-J Yoon; J J Zimmerman; K M Harmon; P M Dixon; C M T Dvorak; M P Murtaugh
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain.

Authors:  E H J Wissink; H A R van Wijk; M V Kroese; E Weiland; J J M Meulenberg; P J M Rottier; P A van Rijn
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

9.  Genomic characterization of two Chinese isolates of porcine respiratory and reproductive syndrome virus.

Authors:  Z Q Gao; X Guo; H C Yang
Journal:  Arch Virol       Date:  2004-03-17       Impact factor: 2.574

10.  Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus.

Authors:  M P Murtaugh; M R Elam; L T Kakach
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.